Balanced news tone
News Sentiment
CV sentiment intelligence
CapsoVision, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
78/100 classification confidence.
directly relevant articles
high-authority source matches
+12.0% over one week, +1.5% over four weeks, trend inactive, and near fair-value range.
Vista Energy SAB de CV (VIST) Stock Up 3.0% and Still Undervalued -- GF Score: 86/100
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Vista Energy SAB de CV (VIST) Stock Up 3.0% and Still Undervalued -- GF Score: 86/100
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jul 2026 22:02
- Source
- GuruFocus
Here's How FEMSA Stock is Poised Ahead of Q2 Earnings Release
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Jul 2026 17:19
- Source
- TradingView
VLRS Stock 12‑Month Price Target Raised to $9.56, Implies 20% Upside
- Tone
- Positive 80/100
- Event
- Analyst action
- Published
- 22 Jul 2026 07:20
- Source
- TradingView
CapsoVision director Eliyahou Harari buys $410k in company stock By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jul 2026 23:35
- Source
- Investing.com Canada
CapsoVision 10% owner Eliyahou Harari reports purchase of 61,068 common shares for $410,987.64
Eliyahou Harari, a 10% owner of CapsoVision, has reported the purchase of 61,068 common shares for a total of $410,987.64. The shares were bought at a price of USD 6.73 each, increasing his indirect stake through a trust to 3.34 million shares. This news brief was generated by Pu
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 21 Jul 2026 23:09
- Source
- Bitget
Abbott stock trades steady as diagnostics and medical devices underpin earnings momentum
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Jul 2026 13:10
- Source
- Ad-hoc-news.de
Abbott Laboratories stock trades steadily as diagnostics and medical devices underpin earnings momen
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Jul 2026 02:00
- Source
- Ad-hoc-news.de
Cemex SAB de CV (CX) Stock Down 3.7% but Still Overvalued -- GF Score: 73/100
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jul 2026 22:10
- Source
- GuruFocus
Tata Motors CV Share Price Today, Tata Motors CV Stock Price Live NSE/BSE Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jul 2026 21:53
- Source
- The Economic Times
UPG UK & Ireland’s stock-led strategy ‘resonates with CV sector’ at RTX 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jul 2026 18:13
- Source
- Tyrepress
VINTE Stock Price and Chart — BMV:VINTE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 07:00
- Source
- TradingView
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
CapsoVision 10% owner Eliyahou Harari buys $495,117 in stock By Investing.com
Eliyahou Harari, a 10% owner of CapsoVision Inc., purchased 81,300 shares of the company's common stock for $495,117, despite the stock's recent decline and overvalued assessment by InvestingPro. This insider transaction follows the company's first-quarter 2026 earnings miss and
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 Jul 2026 15:11
- Source
- Investing.com Nigeria
Form 4 CapsoVision Inc For: 10 July By Investing.com
This article from Investing.com is a brief financial update indicating the filing of a Form 4 for CapsoVision Inc. on July 10. The article is very short and primarily serves as a notification, mentioning a 3.81% increase for the company's stock symbol CV.
- Tone
- Positive 61/100
- Event
- Market update
- Published
- 11 Jul 2026 14:11
- Source
- Investing.com South Africa
Insider Buyers Lose US$22k As CapsoVision Sheds US$75m
Insiders at CapsoVision (NASDAQ:CV) who purchased US$101.8k worth of stock at an average price of US$7.35 over the past year have seen their investment decrease by 21%, now worth US$79.9k. Despite this loss, the single insider purchase by Britt Harari at a price above the current
- Tone
- Negative 36/100
- Event
- Market update
- Published
- 10 Jul 2026 10:39
- Source
- Simply Wall Street
Form 4 CapsoVision Inc For: 7 July By Investing.com
This article announces the filing of Form 4 for CapsoVision Inc. on July 7th, as reported by Investing.com. It is a brief financial news update providing disclosure of insider transactions for the company, identified by the stock symbol CV.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 02:40
- Source
- Investing.com UK
CapsoVision 10% owner Eliyahou Harari buys $101,811 in CV stock
Eliyahou Harari, a 10% owner of CapsoVision, Inc. (CV), purchased 13,850 shares of the company's common stock for $101,811 on June 26, 2026, at $7.351 per share. This insider purchase occurred despite the stock currently trading at $5.67, approximately 23% below his purchase pric
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 08 Jul 2026 02:11
- Source
- Investing.com
Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 04 Jul 2026 07:00
- Source
- timothysykes.com
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
CapsoVision, Inc. has appointed Dr. David S. Shields, a distinguished gastroenterologist with over 40 years of experience, to its Board of Directors, effective July 1, 2026. Dr. Shields has been a clinical advisor to CapsoVision for nearly a decade and will bring extensive expert
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 03 Jul 2026 11:40
- Source
- GlobeNewswire
Press Release: CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
CapsoVision, Inc., a company focused on advanced capsule endoscopy solutions, announced the appointment of Dr. David S. Shields, a prominent leader in gastroenterology, to its Board of Directors. Dr. Shields brings extensive experience in GI practice management, clinical research
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 02 Jul 2026 23:40
- Source
- Moomoo
CapsoVision appoints gastroenterologist David Shields to board
CapsoVision, Inc. has appointed Dr. David S. Shields, a board-certified gastroenterologist with over 40 years of experience, to its Board of Directors. Dr. Shields has served as a clinical advisor to CapsoVision for nearly a decade and succeeds Dr. Joanne C. Imperial, who will co
- Tone
- Positive 60/100
- Event
- Market update
- Published
- 02 Jul 2026 21:13
- Source
- Investing.com
Gastroenterology leader Shields joins CapsoVision (Nasdaq: CV) board as Imperial shifts to consulting
CapsoVision, Inc. (Nasdaq: CV) has appointed Dr. David S. Shields, a prominent gastroenterologist, to its Board of Directors and Compensation Committee, effective July 1, 2026. Dr. Shields replaces Dr. Joanne Imperial, who resigned from the board but will continue to serve CapsoV
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Jul 2026 20:09
- Source
- Stock Titan
Director at CapsoVision (CV) awarded 1,710 RSUs vesting in 2026
CapsoVision, Inc. director David Stanley Shields has been awarded 1,710 Restricted Stock Units (RSUs) as a compensation grant, with each RSU representing a contingent right to receive one share of common stock. These RSUs were granted at a price of $0.0000 per unit and are schedu
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 20:09
- Source
- Stock Titan
Director Tsai Chen Lung adds CapsoVision (CV) shares via RSU vesting
CapsoVision director Tsai Chen Lung increased his direct equity stake by exercising 2,022 Restricted Stock Units (RSUs) into Common Stock on June 30, 2026. These RSUs were part of an equity incentive award, vesting 50% on June 30 and 50% on December 31 each year. After the transa
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 02 Jul 2026 13:41
- Source
- Stock Titan
CapsoVision director Joanne Imperial sells $8,586 in common stock
CapsoVision director Joanne Imperial sold 1,200 shares of company common stock for $8,586 on June 8, 2026. This transaction occurred amidst news of CapsoVision missing Q1 2026 EPS expectations, though the company has ongoing product development and recently re-elected directors.
- Tone
- Negative 40/100
- Event
- Earnings
- Published
- 02 Jul 2026 11:40
- Source
- Investing.com
Grupo Aeromexico, S.A.B. de C.V. Stock 12‑Month Price Target Raised to $27.1, Implies 54% Upside
- Tone
- Positive 80/100
- Event
- Analyst action
- Published
- 02 Jul 2026 07:00
- Source
- TradingView
Why Tenet Healthcare (THC) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- TradingView
Vista Energy S.A.B. de C.V. Stock 12‑Month Price Target Cut to $99.6, Implies 59% Upside
- Tone
- Negative 35/100
- Event
- Analyst action
- Published
- 02 Jul 2026 07:00
- Source
- TradingView
CapsoVision director Joanne Imperial sells $8,586 in common stock By Investing.com
CapsoVision director Joanne Imperial sold 1,200 shares of company common stock for $8,586 on June 8, 2026. This transaction leaves Ms. Imperial with 1,687 shares, while the stock is currently trading at $7.37, marking a 31% year-to-date decline despite a 110% gain over the past y
- Tone
- Negative 33/100
- Event
- Market update
- Published
- 02 Jul 2026 02:09
- Source
- Investing.com South Africa
CapsoVision (CV) director converts RSUs into 2,022 common shares in equity grant vesting
CapsoVision, Inc. director King Wen-Herng Henry converted 2,022 restricted stock units (RSUs) into common shares on June 30, 2026, as part of an equity grant vesting. The shares were acquired at $7.58 each, stemming from an RSU grant made on March 19, 2026, with a fair market val
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 03:13
- Source
- Stock Titan